Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis

Journal of Immunology

Volumn 177, Issue 8, 2006, Pages 5585-5594

  Lee, Mi Sook ^a   Yoo, Seung Ah ^b   Cho, Chul Soo ^b   Suh, Pann Ghill ^a   Kim, Wan Uk ^b,c   Ryu, Sung Ho ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ACUTE PHASE PROTEIN; CALCIUM; CYCLIN D1; FAS ANTIBODY; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR LIKE 1; IMMUNOGLOBULIN M; MITOGEN ACTIVATED PROTEIN KINASE; NITROPRUSSIDE SODIUM; PROTEIN BCL 2; PROTEIN KINASE B; SERUM AMYLOID A; SMALL INTERFERING RNA; TRYPTOPHYLLYSYLTYROSYLMETHIONYLVALYLMETHIONINE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE DESTRUCTION; CALCIUM CELL LEVEL; CARTILAGE DEGENERATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HUMAN; HUMAN CELL; HYPERPLASIA; INFLAMMATORY DISEASE; LIGAND BINDING; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RHEUMATOID ARTHRITIS; STATISTICAL ANALYSIS; SYNOVIOCYTE; WESTERN BLOTTING;

EID: 33749529307     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.8.5585     Document Type: Article

References (57)

1. Cornélis, F., S. Fauré, M. Martinez, J. F. Prud'homme, P. Fritz, C. Dib, H. Alves, P. Barrera, N. de Vries, A. Balsa, et al. 1998. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc. Natl. Acad. Sci. USA 95: 10746-10750.
2. Kinne, R. W., R. Bräuer, B. Stuhlmüller, E. Palombo-Kinne, and G. R. Burmester. 2000. Macrophages in rheumatoid arthritis. Arthritis Res. 1: 189-202.
3. Pap, T., U. Müller-Ladner, R. E. Gay, and S. Gay. 2000. Fibroblast biology: role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 5: 361-367.
4. Koch, A. E. 2003. Angiogenesis as a target in rheumatoid arthritis. Ann. Rheum. Dis. 62: ii60-ii67.
5. Feldmann, M., F. M. Brennan, and R. N. Maini. 1996. Rheumatoid arthritis. Cell 85: 307-310.
6. Firestein, G. S. 1996. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Rheum. 39: 1781-1790.
7. Roivainen, A., J. Jalava, L. Pirila, T. Yli-Jama, H. Tiusanen, and P. Toivanen. 1997. H-ras oncogene point mutations in arthritic synovium. Arthritis Rheum. 40: 1636-1643.
8. Firestein, G. S., F. Echeverri, M. Yeo, N. J. Zvaifler, and D. R. Green. 1997. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc. Natl. Acad. Sci. USA 94: 10895-10900.
9. Schedel, J., R. E. Gay, P. Kuenzler, C. Seemayer, B. Simmen, B. A. Michel, and S. Gay. 2002. FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis. Arthritis Rheum. 46: 1512-1518.
10. Perlman, H., C. Georganas, L. J. Pagliari, A. E. Koch, K. Haines III, and R. M. Pope. 2000. Bcl-2 expression in synovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability. J. Immunol. 164: 5227-5235.
11. Koch, A. E. 1998. Angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum. 41: 951-962.
12. Kimball, E. S., and J. L. Gross. 1991. Angiogenesis in pannus formation. Agents Actions 34: 329-331.
13. Colville-Nash, P. R., and D. L. Scott. 1992. Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann. Rheum. Dis. 51: 919-925.
14. Meek, R. L., and E. P. Benditt. 1986. Amyloid A gene family expression in different mouse tissues. J. Exp. Med. 164: 2006-2017.
15. Meek, R. L., S. Urieli-Shoval, and E. P. Benditt. 1994. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc. Natl. Acad. Sci. USA 91: 3186-3190.
16. Jensen, L. E., and A. S. Whitehead. 1998. Regulation of serum amyloid A protein expression during the acute-phase response. Biochem. J. 334: 489-503.
17. Uhlar, C. M., and A. S. Whitehead. 1999. Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 265: 501-523.
18. Mitchell, T. I., C. I. Coon, and C. E. Brinckerhoff. 1991. Serum amyloid A (SAA3) produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin 1 induces synthesis of collagenase and is neutralized with specific antiserum. J. Clin. Invest. 87: 1177-1185.
19. Vallon, R., F. Freuler, N. Desta-Tsedu, A. Robeva, J. Dawson, P. Wenner, P. Engelhardt, L. Boes, J. Schnyder, C. Tschopp, et al. 2001. Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases. J. Immunol. 166: 2801-2807.
20. Cunnane, G., S. Grehan, S. Geoghegan, C. McCormack, D. Shields, A. S. Whitehead, B. Bresnihan, and O. Fitzgerald. 2000. Serum amyloid A in the assessment of early inflammatory arthritis. J. Rheumatol. 27: 58-63.
21. Baranova, I. N., T. G. Vishnyakova, A. V. Bocharov, R. Kurlander, Z. Chen, M. L. Kimelman, A. T. Remaley, G. Csako, F. Thomas, T. L. Eggerman, and A. P. Patterson. 2005. Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases. J. Biol. Chem. 280: 8031-8040.
22. He, R., H. Sang, and R. D. Ye. 2003. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 101: 1572-1581.
23. Su, S. B., W. Gong, J. L. Gao, W. Shen, P. M. Murphy, J. J. Oppenheim, and J. M. Wang. 1999. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189: 395-402.
24. Le, Y., J. Hu, W. Gong, W. Shen, B. Li, N. M. Dunlop, D. O. Halverson, D. G. Blair, and J. M. Wang. 2000. Expression of functional formyl peptide receptors by human astrocytoma cell lines. J. Neuroimmunol. 111: 102-108.
25. De, Yang, Q. Chen, A. P. Schmidt, G. M. Anderson, J. M. Wang, J. Wooters, J. J. Oppenheim, and O. Chertov. 2000. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192: 1069-1074.
26. Koczulla, R., G. von Degenfeld, C. Kupatt, F. Krötz, S. Zahler, T. Gloe, K. Issbrücker, P. Unterberger, M. Zaiou, C. Lebherz, et al. 2003. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111: 1665-1672.
27. O'Hara, R., E. P. Murphy, A. S. Whitehead, O. FitzGerald, and B. Bresnihan. 2004. Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis. Arthritis Rheum. 50: 1788-1799.
28. Yoo, S. A., D. G. Bae, J. W. Ryoo, H. R. Kim, G. S. Park, C. S. Cho, C. B. Chae, and W. U. Kim. 2005. Arginine-rich anti-vascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-α and IL-6 by human monocytes. J. Immunol. 174: 5846-5855.
29. Guidoboni, M., P. Zancai, R. Cariati, S. Rizzo, C. J. Dal, A. Pavan, A. Gloghini, M. Spina, A. Cuneo, F. Pomponi, et al. 2005. Retinoic acid Inhibits the proliferative response induced by CD40 activation and Interleukin-4 in mantle cell lymphoma. Cancer Res. 65: 587-595.
30. Bauer, S., and P. H. Patterson. 2005. The cell cycle-apoptosis connection revisited in the adult brain. J. Cell Biol. 171: 641-650.
31. Sen, M., J. Reifert, L. Kevin, V. Wolf, J. S. Rubin, M. Corr, and D. A. Carson. 2002. Regulation of fibronectin and metalloproteinase expression by Wnt signaling in rheumatoid arthritis synoviocytes. Arthritis Rheum. 46: 2867-2877.
32. Bae, Y. S., H. Y. Lee, E. J. Jo, I. Kim, H. K. Kang, R. D. Ye, J. Y. Kwak, and S. H. Ryu. 2004. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J. Immunol. 173: 607-614.
33. Kim, W. U., S. Y. Min, M. L. Cho, J. Youn, J. K. Min, S. H. Lee, S. H. Park, C. S. Cho, and H. Y. Kim H. 2000. The role of IL-12 in inflammatory activity of patients with rheumatoid arthritis (RA). Clin. Exp. Immunol. 119: 175-181.
34. Harhun, M. I., D. V. Gordienko, O. V. Povstyan, R. F. Moss, and T. B. Bolton. 2004. Function of interstitial cells of Cajal in the rabbit portal vein. Circ. Res. 95: 619-626.
35. Lee, M. S., E. J. Moon, S. W. Lee, M. S. Kim, K. W. Kim, and Y. J. Kim. 2001. Angiogenic activity of pyruvic acid in in vivo and in vitro angiogenesis models. Cancer Res. 61: 3290-3293.
36. Kim, M. S., H. J. Kwon, Y. M. Lee, J. H. Baek, J. E. Jang, S. W. Lee, E. J. Moon, H. S. Kim, S. K. Lee, H. Y. Chung, et al. 2001. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat. Med. 7: 437-443.
37. Le, Y., W. Gong, B. Li, N. M. Dunlop, W. Shen, S. B. Su, R. D. Ye, and J. M. Wang. 1999. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J. Immunol. 163: 6777-6784.
38. 4 receptor. Blood 95: 1810-1818.
39. Sounni, N. E., L. Devy, A. Hajitou, F. Frankehne, C. Munaut, C. Gilles, C. Deroanne, E. W. Thompson, J. M. Foidart, and A. Noel. 2002. MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J. 16: 555-564.
40. Ferrari, N., U. Pfeffer, R. Dell'Eva, C. Ambrosini, D. M. Noonan, and A. Albini. 2005. The transforming growth factor-β family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide. Clin. Cancer Res. 11: 4610-4619.
41. Kramer, I., A. Wilulswas, K. Croft, and E. Genot. 2003. Rheumatoid arthritis: targeting the proliferative fibroblast. Prog. Cell Cycle Res. 5: 59-70.
42. Mohr, W., G. Beneke, and W. Mohing. 1975. Proliferation of synovial lining cells and fibroblasts. Ann. Rheum. Dis. 34: 219-224.
43. Matsmoto, S., U. Müller-Ladner, R. E. Gay, K. Nishioka, and S. Gay. 1996. Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. J. Rheumatol. 23: 1345-1352.
44. Ceponis, A., J. Hietanen, M. Tamulaitiene, G. Partsch, H. Pätiälä, and Y. T. Konttinen. 1999. A comparative morphometric study of cell apoptosis in synovial membranes in psoriatic, reactive and rheumatoid arthritis. Rheumtology 38: 431-440.
45. Aupperle, K. R., D. L. Boyle, M. Hendrix, E. A. Seftor, N. J. Zvaifler, M. Barbosa, and G. S. Firestein. 1998. Regulation of synoviocytes proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. Am. J. Pathol. 152: 1091-1098.
46. Borderie, D., P. Hilliquin, A. Hernvann, H. Lemarechal, C. J. Menkes, and O. G. Ekindjian. 1999. Apoptosis induced by nitric oxide is associated with nuclear p53 protein expression in cultured osteoarthritic synoviocytes. Osteoarthritis Cartilage 7: 203-213.
47. Santiago, B., M. Galindo, G. Palao, and J. L. Pablos. 2004. Intracellular regulation of Fas-induced apoptosis in human fibroblasts by extracellular factors and cycloheximide. J. Immunol. 172: 560-566.
48. 4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. J. Biol. Chem. 276: 21585-21593.
49. Hu, J. Y., Y. Le, W. Gong, N. M. Dunlop, J. L. Gao, P. M. Murphy, and J. M. Wang. 2001. Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1. J. Leukocyte Biol. 70: 155-161.
50. Rubinfeld, H., and R. Seger. 2005. The ERK cascade: a prototype of MAPK signaling. Mol. Biotechnol. 31: 151-174.
51. Krause, A., N. Scaletta, J. D. Ji, and L. B. Ivashkiv. 2002. Rheumatoid arthritis synoviocyte survival is dependent on Stat3. J. Immunol. 169: 6610-6616.
52. Morita, Y., N. Kashihara, M. Yamamura, H. Okamoto, S. Harada, and M. Kawashima. 1998. Antisense oligonucleotides targeting c-Fos mRNA inhibit rheumatoid synovial fibroblast proliferation. Ann. Rheum. Dis. 57: 122-124.
53. Pugazhenthi, S., A. Nesterova, C. Sable, K. A. Heidenreich, L. M. Boxer, L. E. Heasley, and J. E. Reusch. 2000. Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J. Biol. Chem. 275: 10761-10766.
54. Piirainen, H. I., A. T. Helve, T. Tornroth, and T. E. Pettersson. 1989. Amyloidosis in mixed connective tissue disease. Scand. J. Rheumatol. 18: 165-168.
55. Furlaneto, C. J., and A. Campa. 2000. A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-α, interleukin-1β, and interleukin-8 by human blood neutrophil. Biochem. Biophys. Res. Commun. 268: 405-408.
56. Mullan, R. H., B. Bresnihan, L. Golden-Mason, T. Markham, R. O'hara, O. Fitzgerald, D. J. Veale, and U. Fearon. 2006. Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-κB-dependent signal transduction pathway. Arthritis Rheum. 54: 105-114.
57. Patel, H., R. Fellowes, S. Coade, and P. Woo. 1998. Human serum amyloid A has cytokine-like properties. Scand. J. Immunol. 48: 410-418.